{
    "2021-12-31": [
        [
            {
                "time": "",
                "original_text": "药明康德晋升施明为首席财务官",
                "features": {
                    "keywords": [
                        "药明康德",
                        "施明",
                        "首席财务官",
                        "晋升"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259.SH)：部分A股首发募投项目延期及变更资金用途 项目问题",
                "features": {
                    "keywords": [
                        "药明康德",
                        "募投项目",
                        "延期",
                        "变更资金用途"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "药明康德(603259.SH)：高级财务副总裁施明晋升为首席财务官",
                "features": {
                    "keywords": [
                        "药明康德",
                        "施明",
                        "首席财务官",
                        "晋升"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "中国CXO行业跟踪报告",
                "features": {
                    "keywords": [
                        "CXO",
                        "行业跟踪报告"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "杀入新冠口服药赛道股价飙升！广生堂利润空间缩减现金流如何支撑？",
                "features": {
                    "keywords": [
                        "新冠口服药",
                        "广生堂",
                        "股价飙升",
                        "利润空间缩减",
                        "现金流"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物制药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "遇见“元素” | 药明康德2021年度回顾",
                "features": {
                    "keywords": [
                        "药明康德",
                        "2021年度回顾",
                        "元素"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "CXO"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}